SEC Form 4 · accession 0000899243-16-027038
Nuo Therapeutics, Inc. · AURX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles E Sheedy
10% Owner
Period of report
Jun 20, 2016
Accepted (ET)
Aug 15, 2016 · 11:45 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001091596
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF1 | Jun 20, 2016 | J | 10,000 | — | A | 3,066,312 | D | |
| Common Stock, par value $0.0001 per shareF2 | holding | — | — | — | 3,365 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares of Common Stock, par value $0.0001 per share (the "New Shares"), of Nuo Therapeutics, Inc. (the "Issuer") were issued pursuant to an order of the United States Bankruptcy Court for the District of Delaware dated June 20, 2016 to the Reporting Person as a designee of the ad hoc committee of equity holders of the Issuer as repayment for a $10,000 loan made by the Reporting Person to the committee in December 2015.
- F2Shares held in separate trusts for the benefit of children of the Reporting Person (673 shares in each of 5 trusts). The Reporting Person disclaims beneficial ownership over such shares except to the extent of his pecuniary interest therein.